Prostate Cancer - Jan 2, 2024 - Study sheds light on enzyme's role in advanced prostate cancer progression

Can't see this email? View it online

	Prostate Cancer
	The latest prostate cancer news from News Medical

	Study sheds light on enzyme's role in advanced prostate cancer progression Prostate cancer is the most common cancer in men other than skin cancer, and more than 288,000 new cases are diagnosed every year, according to the American Cancer Society.

	HPV infections increase prostate cancer risk by 2.3 times, study finds Study investigates the association between HPV infections and prostate cancer, revealing that HPV patients have a 2.3-fold increased risk of developing prostate cancer compared to those without HPV.

			Exploiting enzymes in cancer diagnosis and therapy As enzymes are involved at every stage of cell regulation, a better understanding of their role and function allows them to be exploited in the clinic, both as diagnostic and therapeutic agents.

			Study exploits biomolecular condensates to inhibit androgen receptor in prostate cancer Transcription factors play essential roles in turning the genetic information encoded in genes into proteins in all cells and organisms.

			New study unlocks hope for immunotherapy in metastatic prostate cancer Immunotherapy has been disappointing as a prostate cancer treatment, but a new Columbia study suggests that the powerful treatments have potential when the disease starts to spread.

	Organoid models for cancer research This article describes Organoids' features and their role in cancer research.

	Trends in mortality from leading cancers from 2002 to 2019 for the 314 districts in England Researchers assessed mortality trends in the leading cancers from 2002 to 2019 across 314 districts in England using high-resolution spatiotemporal analysis.

	Are there racial and ethnic disparities in the use of novel hormonal therapy agents in men with advanced prostate cancer? Researchers assessed ethnic and racial differences in novel hormonal therapy (NHT) use among advanced prostate cancer (PCa) patients.

	UCLA studies unravel metabolic pathways in prostate cancer treatment Two new studies led by researchers from the UCLA Jonsson Comprehensive Cancer Center give insight into how cells use energy to influence the way prostate tumors survive and grow -; advancements that can help explain why some prostate cancers become resistant to hormone therapy, the most commonly used treatment for men with advanced stages of the disease.

	Using AI and image analysis to study solid tumors In this article, Cerba details how AI and image analysis were using in the quantification of Ki-67 in solid tumors.

	UCLA researchers receive $3 million to develop AI for aggressive prostate cancer detection Researchers at the UCLA Health Jonsson Comprehensive Cancer Center have received a five-year, $3 million grant from the National Cancer Institute to identify novel cancer biomarkers and develop AI that can detect and predict aggressive prostate cancer to help avoid unnecessary treatments and their associated negative side effects.

	Exploring the role of liquid biopsies in early-stage prostate cancer A new research perspective was published in Oncoscience (Volume 10) on November 30, 2023, entitled, "Evolving insights in blood-based liquid biopsies for prostate cancer interrogation."

Website: www.news-medical.net

Email: [email protected]

Telephone: +44 (0)161 457 7150

AZoNetwork UK Ltd.
NEO, 4th Floor
9 Charlotte Street, Manchester
M1 4ET, UK

Why did you receive this email?
You recently requested related information from us and asked to be notified of additional information.

Not interested anymore?
Unsubscribe or
Update Your Newsletter Subscriptions